Baldwin Files Preliminary Proxy for $32.50/Share Take-Private by Sequence and DFO
BWIN has more than doubled off its 52-week low of $15.88 on light trading volume (0.4× avg).
Summary
Baldwin filed its preliminary proxy for the $32.50-per-share cash take-private by Sequence Holdings and DFO Management, disclosing fairness opinions, a capped $298.45 million TRA termination payment, and committed financing. Shareholders will vote at a special meeting; closing is expected in Q1 2027.
Key Events · M&A and Partnerships · BWIN
-
Take-Private at $32.50 Cash Per Share
Sequence Holdings and DFO Management will acquire Baldwin for $32.50 per share in cash, an 87.5% premium to the $17.33 unaffected price on June 17, 2026 and 9.6% above the $29.65 close on September 11, 2026.
-
Fairness Opinions and Board Recommendation
Perella Weinberg (Special Committee) and Ardea Partners (Board) each delivered opinions that $32.50 per share is fair from a financial point of view; the Board and Special Committee unanimously recommend approval.
-
TRA Termination Capped at $298.45 Million
The Tax Receivable Agreement will be terminated for aggregate Final TRA Payments capped at $298,450,598, a roughly 20% discount to estimated early termination payments that increased merger consideration by $0.50 per share.
-
Fully Committed Financing
DFO committed up to $4,599,000,000 of equity, and lenders committed a $2.75 billion term loan, $415 million delayed draw term loan, and $500 million revolver; the merger is not conditioned on financing.
Analysis · BWIN · Finance
Shareholders now have the preliminary proxy for the special meeting to vote on the $32.50-per-share cash take-private by Sequence Holdings and DFO Management. Announced September 14, 2026, the deal's material terms are laid out here: both financial advisors—Perella Weinberg for the Special Committee and Ardea for the Board—delivered fairness opinions; the Tax Receivable Agreement will be terminated for a capped $298.45 million payment, a roughly 20% discount that added $0.50 per share to the price; and the merger is fully financed with a $4.599 billion DFO equity commitment and committed debt. Approval is unanimously recommended by the Board and Special Committee. The vote is the key remaining gating item, with closing expected in Q1 2027 and an HSR waiting period scheduled to expire November 4, 2026.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 37.1% of the 974 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.64%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BWIN was trading at $31.97 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $15.88 to $32.71. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.